Pharmaceutical Compliance Solutions

Solutions Proactive Risk Mitigation Responding to Government Action Learning Programs

Pharmaceutical Compliance Solutions

The Office of the Inspector General (“OIG”) has called for all pharmaceutical and biotech companies to “…establish a comprehensive Field Force Monitoring Program to evaluate and monitor its sales representatives’ interactions with HCPs and HCIs” and to create “…a formalized process designed to directly and indirectly observe… interactions with HCPs and HCIs and to identify potential off-label promotional activities or other improper conduct.”

The I GLASS™ tool and WLH’s expert consulting solutions provide defensible processes that can bring an organization’s compliance program up to speed with evolving policy demands and help defend them from civil and criminal prosecution.